These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 31072227

  • 1. Rapid Involution of Large Cardiac Rhabdomyomas With Everolimus Therapy.
    Garg A, Gorla SR, Kardon RE, Swaminathan S.
    World J Pediatr Congenit Heart Surg; 2021 May; 12(3):426-429. PubMed ID: 31072227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Everolimus for the Treatment of Tuberous Sclerosis Complex-Related Cardiac Rhabdomyomas in Pediatric Patients.
    Dahdah N.
    J Pediatr; 2017 Nov; 190():21-26.e7. PubMed ID: 28888564
    [No Abstract] [Full Text] [Related]

  • 4. Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia.
    Öztunç F, Atik SU, Güneş AO.
    Cardiol Young; 2015 Oct; 25(7):1411-4. PubMed ID: 26339757
    [Abstract] [Full Text] [Related]

  • 5. Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.
    Colaneri M, Quarti A, Pozzi M.
    Cardiol Young; 2016 Jun; 26(5):1025-8. PubMed ID: 27055516
    [Abstract] [Full Text] [Related]

  • 6. Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial.
    Stelmaszewski EV, Parente DB, Farina A, Stein A, Gutierrez A, Raquelo-Menegassio AF, Manterola C, de Sousa CF, Victor C, Maki D, Morón EM, de Abrantes FF, Iqbal F, Camacho-Vilchez J, Jimenez-Pavón J, Polania JP, Thompson L, Bonanato L, Diebold M, Da Silva MVCP, Nashwan MWJ, Galvani MAG, Idris OEA, Danos P, Ortiz-Lopez R, Mahmoud RAA, Gresse S, Loss KL.
    Cardiol Young; 2020 Mar; 30(3):337-345. PubMed ID: 31983379
    [Abstract] [Full Text] [Related]

  • 7. Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas.
    Silva-Sánchez MP, Alvarado-Socarras JL, Castro-Monsalve J, Meneses KM, Santiago J, Prada CE.
    Am J Med Genet A; 2021 May; 185(5):1525-1531. PubMed ID: 33590972
    [Abstract] [Full Text] [Related]

  • 8. Use of everolimus for cardiac rhabdomyomas in a very-low-birthweight infant.
    Tsuchihashi T, Tsuno Y, Kakimoto N, Riko M, Kumagai T.
    Pediatr Int; 2021 Jun; 63(6):726-727. PubMed ID: 34038023
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature.
    Martínez-García A, Michel-Macías C, Cordero-González G, Escamilla-Sánchez KI, Aguinaga-Ríos M, Coronado-Zarco A, Cardona-Pérez JA.
    Cardiol Young; 2018 Jul; 28(7):903-909. PubMed ID: 29759095
    [Abstract] [Full Text] [Related]

  • 12. Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss.
    Çetin M, Aydın AA, Karaman K.
    Cardiol Young; 2021 Aug; 31(8):1359-1362. PubMed ID: 33658088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.
    Goyer I, Dahdah N, Major P.
    Pediatr Neurol; 2015 Apr; 52(4):450-3. PubMed ID: 25682485
    [Abstract] [Full Text] [Related]

  • 15. Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatment.
    Yıldırım S, Aypar E, Aydın B, Akyüz C, Aykan HH, Ertuğrul İ, Karagöz T, Alehan D.
    Turk J Pediatr; 2023 Apr; 65(3):479-488. PubMed ID: 37395967
    [Abstract] [Full Text] [Related]

  • 16. Regression of a cardiac rhabdomyoma in a patient receiving everolimus.
    Tiberio D, Franz DN, Phillips JR.
    Pediatrics; 2011 May; 127(5):e1335-7. PubMed ID: 21464184
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma.
    Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP.
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31088894
    [Abstract] [Full Text] [Related]

  • 19. Rapid regression everolimus therapy in a neonate with cardiac rhabdomyoma.
    Çetiner N, Kavas N, Küçükosmanoğlu O.
    Pediatr Int; 2022 Jan; 64(1):e15188. PubMed ID: 35605248
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.